Zoetis

Traded on the St. Petersburg Stock Exchange
Zoetis is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Zoetis include in the S&P 500 index.
Zoetis stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Zoetis balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Zoetis cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Zoetis multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Zoetis profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Zoetis assets
Zoetis cash flows
Zoetis dividends
1.18%

Zoetis shares

TickerNameTypeNominal valueISINPrice
ZTS:USZoetis Inc. Class ACommon share-US98978V1035$174.6
Zoetis news
20.05.2022
The Zoetis Board of Directors announced a quarterly dividend of $0.325 per share. The last day to buy securities to receive the dividend is July 19, 2022. The annual dividend yield may reach 0.64%.
Source: {source} pictogram investor.zoetis.com
Pictogram next
05.05.2022
Zoetis' GAAP net income for 3 months of 2022 was $594 million, up 6.5% from $558 million in the previous year. Revenue increased 6.1% to $1.986 billion from $1.871 billion a year earlier.
Source: {source} pictogram investor.zoetis.com
Pictogram next
15.02.2022
Zoetis' GAAP net income for 2021 was $2.037 billion, up 24.4% from $1.638 billion in the previous year. Revenue increased 16.5% to $7.776 billion from $6.675 billion a year earlier.
Source: {source} pictogram investor.zoetis.com
Pictogram next
09.02.2022
Zoetis shareholders approved a $0.325 per common share dividend for the sixth month of 2022. The last day to purchase securities to receive the dividend is April 19, 2022. The dividend yield could be 0.16%.
Source: {source} pictogram investor.zoetis.com
Pictogram next
All Zoetis news
General information
Company nameZoetis
Tags#pharmacy, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Mailing address10 SYLVAN WAY PARSIPPANY NJ 07054
Websiteinvestor.zoetis.com
Information disclosurewww.sec.gov